RxDoctor Payments Data

Matthew Fackrell

Family Medicine · Blackfoot, IDNPI 1215968045

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 319 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 42 manufacturers reported payments, led by AbbVie at 24.9% of the total. Among family medicine clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,078in general payments, 2019–2025

Across 319 payments — averaging $15.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$414
  • Lilly USA, LLC$399
  • Astellas Pharma US Inc$216
  • Vanda Pharmaceuticals Inc.$201
  • Pfizer$190
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$5,064100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,078 in reported general payments places this provider in the 90th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide171$164,122
MounjaroTirzepatide113$120,335
EliquisApixaban93$90,450
TrulicityDulaglutide68$64,712
Invega SustennaPaliperidone Palmitate17$51,647
XareltoRivaroxaban51$48,342
VraylarCariprazine Hcl27$39,388
FarxigaDapagliflozin Propanediol39$37,409
MyrbetriqMirabegron30$27,038
JardianceEmpagliflozin18$20,562
JanuviaSitagliptin Phosphate26$18,614
Celecoxib203$16,327
Lantus SolostarInsulin Glargine,hum.Rec.Anlog123$15,756
LinzessLinaclotide23$13,772
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$399$185,047181 claims
Novo NordiskOzempic$414$164,122171 claims
Johnson & JohnsonInvega Sustenna, Xarelto$171$99,98968 claims
PfizerEliquis, Premarin$190$95,725105 claims
AbbVieVraylar, Linzess$1,267$53,16050 claims
AstraZenecaFarxiga, Symbicort$66$41,27355 claims
Astellas Pharma US IncMyrbetriq$216$27,03830 claims
Boehringer IngelheimJardiance, Combivent Respimat$127$26,05730 claims
MerckJanuvia, Dulera$36$25,71247 claims
GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta$134$21,42253 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$21$5,92111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 803 family medicine providers in Idaho.

Other family medicine in Blackfoot

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →